These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 617340)

  • 1. Lipodystrophic diabetes treated with fenfluramine.
    Trygstad O; Seip M; Oseid S
    Int J Obes; 1977; 1(3):287-92. PubMed ID: 617340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial lipodystrophy and insulin-resistant diabetes.
    Crome P; Keen H
    Diabete Metab; 1978 Jun; 4(2):81-4. PubMed ID: 680314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the effects of 780SE on carbohydrate tolerance and plasma hormone and lipid profile in maturity-onset diabetes.
    Asmal AC; Leary WP
    Postgrad Med J; 1975; 51 Suppl 1(593):144-8. PubMed ID: 768955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucose tolerance, insulin and lipids in adipose patients following one week of fenfluramine administration].
    Schwandt P; Weisweiler P
    Verh Dtsch Ges Inn Med; 1975; 81():1473-5. PubMed ID: 1227001
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of fenfluramine on obese, maturity-onset diabetic patients.
    Wales JK
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):616-23. PubMed ID: 373358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
    Hamet P; Verdy I; Chiasson JL; Verdy M
    Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful insulin therapy in lipoatrophic diabetes].
    Böhmer K; Hauner H; Phlippen R; Gries FA
    Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of fenfluramine in diabetes mellitus.
    Joasoo A; Turtle JR
    Postgrad Med J; 1975; 51 Suppl 1():133. PubMed ID: 1219670
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amenorrhea, ptosis and high insulin requirement in a young girl.
    Hari Kumar KV; Kumar S
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S151-3. PubMed ID: 26482962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenfluramine in management of obese diabetics.
    Misra NP; Bhambal SA; Yesikar SS; Bellani RK
    J Assoc Physicians India; 1980 Sep; 28(9):287-95. PubMed ID: 7007309
    [No Abstract]   [Full Text] [Related]  

  • 17. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
    Cardona-Hernández R; Suárez-Ortega L; Torres M
    An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy.
    Rognum TO; Bjerve KS; Seip M; Trygstad O; Oseid S
    Acta Endocrinol (Copenh); 1978 May; 88(1):182-9. PubMed ID: 580534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucose tolerance, insulin and lipids after one week's administration of fenfluramine to overweight patients (author's transl)].
    Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1975 Nov; 117(48):1925-8. PubMed ID: 813120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.